Type 2 Diabetes

Patients with diabetes often develop thiamine deficiency secondary to elevated blood sugar. This deficiency is so common that some experts have referred to it as an epidemic.

A once-weekly self-injection pen has been approved by the FDA to supplement diet and exercise for type 2 diabetes patients.

Similar to its effect in non-diabetic patients with low testosterone, sildenafil citrate correlates with improvements in testosterone levels and erectile function among hypogonadal men with type 2 diabetes mellitus.

A recent issue of the Journal of the American Medical Association includes a picture series that is a must-see for physicians who treat patients with diabetes.

Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.

A review of the cardiovascular safety and potential benefits of incretin-based therapies for patients with type 2 diabetes mellitus.

Researchers estimate 43% of the roughly 3.1 million kidney stone episodes among US diabetics are related to type 2 diabetes mellitus (T2DM), while another 680,000 cases may result from poor glycemic control.

Researchers at Tufts University have published a timely review of the cranberry's phytochemical composition with emphasis on urinary and cardiovascular heath.

A researcher from the University of Central Florida Medical School addresses many concerns and misperceptions of fructose-containing sugars.

Results from a small study indicate patients with difficult-to-treat diabetic peripheral neuropathy (DPN) may benefit from therapy with tanezumab, a humanized monoclonal antibody against nerve growth factor.

Researchers in Taiwan report that type 2 diabetes is independently associated with increased risk of peptic ulcer bleeding.

The American Diabetes Association revised Standards of Medical Care for patients with diabetes include several changes in recommendations regarding testing and treatment goals.

Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.

Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.

Increasing numbers of people are on kidney transplant waiting lists. However, the number of potential living donors may shrink as more Americans qualify as pre-diabetic, making them less than ideal donor candidates.

New research suggests that Interpersonal Psychotherapy may be an effective option for treating major depression in patients with type 2 diabetes mellitus.

Promising initial results from a Phase 3 trial of DiaPep277 have raised hopes that an alternative to insulin may soon be available to treat type 1 diabetes.

According to a nationwide review of data from the in-patient register, 31 of the 33 autoimmune diseases studied were associated with an increased risk of pulmonary embolism (a blood clot on the lung), including type 1 diabetes.

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

Scientists at Stanford University have identified a pathway responsible for age-related beta cell decline.

A recent study has found that it can be very difficult for children who suffer from both type 1 diabetes and asthma to regulate their blood sugar.

Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.

A new study has found that increasing muscle mass may also help lower the risk of the metabolic disease.

A recent study has discovered that early treatment with the diabetes drug metformin may prevent or delay the development of PCOS in young girls.

Real-time blood sugar and insulin infusion data displayed in the electronic medical record allows physicians to tailor treatment and get more patients to goal.